| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Malcolm Lyon | Q43004446 |
| Philippe Lassalle | Q56587363 | ||
| Maryse Delehedde | Q59387446 | ||
| P2093 | author name string | E Adam | |
| S Sarrazin | |||
| F Depontieu | |||
| H Lortat-Jacob | |||
| V Motte | |||
| D Bechard | |||
| C Landolfi | |||
| P2860 | cites work | Systematic variation in gene expression patterns in human cancer cell lines | Q28145747 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 25-37 | |
| P577 | publication date | 2005-08-26 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy | |
| P478 | volume | 1765 |
| Q36415707 | A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis |
| Q38211375 | Aggressive pituitary adenomas--diagnosis and emerging treatments |
| Q41691907 | Angiopoietin-2 Levels as Predictors of Outcome in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome. |
| Q41892380 | Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer. |
| Q87381708 | Biological and clinical implications of endocan in gastric cancer |
| Q35500737 | Characteristics of serum endocan levels in infection |
| Q37564619 | Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics |
| Q92110266 | Circulating endocan and preeclampsia: a meta-analysis |
| Q49722319 | Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma. |
| Q37316926 | Correlation between expression and differentiation of endocan in colorectal cancer |
| Q41472390 | Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer |
| Q42283730 | ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells |
| Q37688603 | ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma |
| Q36840271 | Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea |
| Q64075792 | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
| Q51065264 | Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study. |
| Q50907604 | Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. |
| Q58133817 | Endocan Measurement for Active Behçet Disease |
| Q38797262 | Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension |
| Q28069363 | Endocan and the respiratory system: a review |
| Q61796690 | Endocan as a marker of microvascular inflammation in kidney transplant recipients |
| Q37578395 | Endocan as a prognostic biomarker of triple-negative breast cancer. |
| Q44125824 | Endocan expression correlated with poor survival in human hepatocellular carcinoma |
| Q45226937 | Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors |
| Q37341628 | Endocan immunoreactivity in the mouse brain: method for identifying nonfunctional blood vessels. |
| Q39431959 | Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan |
| Q54456960 | Endocan in hypertension and cardiovascular disease. |
| Q47964690 | Endocan, Obstructive Sleep Apnea, and Vascular Risk |
| Q46843616 | Endocan, a new invasion and angiogenesis marker of pituitary adenomas. |
| Q38984236 | Endocan, a potential prognostic and diagnostic biomarker of acute leukemia |
| Q35547367 | Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes |
| Q92131548 | Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome |
| Q47601818 | Endocan: A Novel Marker of Endothelial Dysfunction in C1-Inhibitor-Deficient Hereditary Angioedema |
| Q35681482 | Endocan: A new marker for cancer and a target for cancer therapy |
| Q38299725 | Endocan: a novel circulating proteoglycan |
| Q87434315 | Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer |
| Q36403585 | Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury |
| Q38103486 | Endothelium and regulatory inflammatory mechanisms during organ rejection. |
| Q42815921 | Establishment of a novel chinese human lung adenocarcinoma cell line CPA-Yang3 and its real bone metastasis clone CPA-Yang3BM in immunodeficient mice |
| Q47380167 | Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients. |
| Q92187464 | Expression of endocan and vascular endothelial growth factor in recurrent minor aphthous ulcers |
| Q37162853 | Expressions of Endocan in Patients with Meningiomas and Gliomas |
| Q94584920 | Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients |
| Q36477174 | Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile |
| Q36116691 | Genomic and proteomic profiling I: leiomyomas in African Americans and Caucasians |
| Q34016310 | Glycosaminoglycans in Human and Bovine Serum: Detection of Twenty-Four Heparan Sulfate and Chondroitin Sulfate Motifs Including a Novel Sialic Acid-modified Chondroitin Sulfate Linkage Hexasaccharide |
| Q35061366 | Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance |
| Q64070314 | Identification of ESM1 overexpressed in head and neck squamous cell carcinoma |
| Q84797546 | Identification of endothelial cell‐specific molecule‐1 as a potential serum marker for colorectal cancer |
| Q37683320 | Identification of fibroblast growth factor-18 as a molecule to protect adult articular cartilage by gene expression profiling |
| Q33845347 | Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis |
| Q39421834 | Immunolocalization of endocan during the endothelial-mesenchymal transition process |
| Q92286808 | Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy |
| Q91814550 | Increase of endocan, a new marker for inflammation and endothelial dysfunction, in acute kidney injury |
| Q90583454 | Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction? |
| Q38207964 | Markers for sepsis diagnosis in the forensic setting: state of the art. |
| Q26766056 | Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion |
| Q37319355 | Molecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: insight from microarray analysis |
| Q36797348 | Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment |
| Q50052184 | Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis. |
| Q47148074 | Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma. |
| Q47105893 | Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression |
| Q37260183 | Plasma endocan level and prognosis of immunoglobulin A nephropathy |
| Q34390721 | Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation |
| Q28075990 | Prognostic value of endocan expression in cancers: evidence from meta-analysis |
| Q47262522 | Protective Effects of Chymostatin on Paraquat-Induced Acute Lung Injury in Mice |
| Q26772304 | Proteoglycans in liver cancer |
| Q49987886 | Relevance of Endothelial Cell-Specific Molecule 1 (Endocan) Plasma Levels for Predicting Pulmonary Infection after Cardiac Surgery in Chronic Kidney Disease Patients: The Endolung Pilot Study. |
| Q90576549 | Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris |
| Q39738902 | Serum Endocan Levels in Children with Febrile Neutropenia |
| Q57056264 | Serum endocan and circadian heart rate variability in non-dialysis stage 5 chronic kidney disease patients |
| Q37657319 | Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. |
| Q36425719 | Serum endocan as a survival predictor for patients with liver cirrhosis |
| Q34042254 | Serum endocan levels in patients with chronic liver disease |
| Q58563180 | Serum endocan levels in patients with stable COPD |
| Q48662822 | Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study |
| Q57805346 | Single-cell RNA sequencing of the mammalian pineal gland identifies two pinealocyte subtypes and cell type-specific daily patterns of gene expression |
| Q41693572 | Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis |
| Q59793529 | The association of elevated circulating endocan levels with lung function decline in COPD patients |
| Q60961723 | The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis |
| Q52587082 | The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis. |
| Q92240932 | Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours |
| Q36630592 | Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane |
Search more.